 The "Taq" polymerase enzyme was also covered by patents.There have been several high-profile lawsuits related to the technique, including an unsuccessful lawsuit brought by DuPont.The Swiss pharmaceutical company Hoffmann-La Roche purchased the rights to the patents in 1992 and currently holds those that are still protected.